The Process Development of Ravuconazole: An Efficient Multikilogram Scale Preparation of an Antifungal Agent

Author:

Pesti Jaan1,Chen Chien-Kuang1,Spangler Lori1,DelMonte Albert J.1,Benoit Serge1,Berglund Derek1,Bien Jeffrey1,Brodfuehrer Paul1,Chan Yeung1,Corbett Elisabeth1,Costello Carrie1,DeMena Paul1,Discordia Robert P.1,Doubleday Wendel1,Gao Zhinong1,Gingras Stephane1,Grosso John1,Haas Oscar1,Kacsur David1,Lai Chiajen1,Leung Simon1,Miller Melanie1,Muslehiddinoglu Jale1,Nguyen Nina1,Qiu Jun1,Olzog Martina1,Reiff Emily1,Thoraval Dominique1,Totleben Michael1,Vanyo Dale1,Vemishetti Purushotham1,Wasylak John1,Wei Chenkou1

Affiliation:

1. Process Research and Development, Bristol-Myers Squibb Pharmaceutical Co., One Squibb Drive, P.O. Box 191, New Brunswick, New Jersey, 08903-0191, U.S.A.

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Reference85 articles.

1. Aspects of this work were also carried out at Bristol-Myers Squibb’s facilities in Princeton, NJ; Candiac, Canada; and Syracuse, NY.

2. Ravuconazole was licensed from Eisai Co. Ltd. References to earlier studies include:

3. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum

4. In Vitro Activity of a New Oral Triazole, BMS-207147 (ER-30346)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3